Balchem Corp. (NASDAQ:BCPC) Director Dino A. Rossi sold 16,400 shares of Balchem Corp. stock in a transaction on Friday, October 7th. The stock was sold at an average price of $78.57, for a total transaction of $1,288,548.00. Following the completion of the sale, the director now owns 23,248 shares of the company’s stock, valued at approximately $1,826,595.36. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

Balchem Corp. (NASDAQ:BCPC) opened at 78.22 on Friday. The firm has a market cap of $2.47 billion, a P/E ratio of 44.44 and a beta of 0.61. Balchem Corp. has a 12-month low of $53.11 and a 12-month high of $79.49. The firm has a 50-day moving average of $70.77 and a 200-day moving average of $64.16.

Balchem Corp. (NASDAQ:BCPC) last issued its quarterly earnings results on Friday, August 5th. The company reported $0.44 EPS for the quarter, missing analysts’ consensus estimates of $0.65 by $0.21. Balchem Corp. had a return on equity of 16.85% and a net margin of 10.18%. The business had revenue of $138.80 million for the quarter, compared to analyst estimates of $134.77 million. On average, analysts expect that Balchem Corp. will post $2.57 EPS for the current year.

Insider Buying and Selling by Quarter for Balchem Corp. (NASDAQ:BCPC)

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at

Separately, Pivotal Research reaffirmed a “hold” rating and issued a $65.00 price objective on shares of Balchem Corp. in a report on Sunday, August 7th.

About Balchem Corp.

Balchem Corporation (Balchem) is engaged in the development, manufacture, distribution and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical and medical sterilization industries. The Company operates in four segments: SensoryEffects, Animal Nutrition & Health (ANH), Specialty Products and Industrial Products.

5 Day Chart for NASDAQ:BCPC

Receive News & Ratings for Balchem Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem Corp. and related companies with's FREE daily email newsletter.